Published on linkedin on June 17th 1. Not enough evidence! When we first embarked on developing Hepatopredict, our idea was very clear: create a biomarker-based test that could reliably inform clinical decisions about liver transplantation… From Promising to Proven: Lessons from the Validation Trenches of Biomarker Development
This reflection was heavily reliant on sourcing information and testing arguments with my favourite AI agent: Perplexity.AI. The ideas, interpretations, and conclusions are mine. The estimates on impact (e.g., life-years gained, cost savings) are approximations… Turning Precision Medicine from Ambition to Impact: Reflecting on a Liver Health Vertical in the UAE
I gave a talk about genomics and the development of precision medicine approaches in Asma at the ASIA meeting 2018 (Associação de Serviços e Unidades de Alergologia). I discussed the challenges of establishing a genomics-based… Speaker: precision medicine in Astma
At the Falar Global show, discussing with Reginaldo Rodrigues de Almeida new technologies in medicine, like genomics and bioinformatics, and the future (and present) of medicine